From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions

Progress in Lipid Research

Volumn 45, Issue 2, 2006, Pages 120-159

  Feige, Jérôme N ^a   Gelman, Laurent ^a   Michalik, Liliane ^a   Desvergne, Béatrice ^a   Wahli, Walter ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Apoptosis; Coactivators; Corepressors; Differentiation; Lipid metabolism; Proliferation; Transcriptional regulation

Indexed keywords

CELL NUCLEUS RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; FATTY ACID; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REGULATOR PROTEIN; SIGNAL PEPTIDE; SUMO PROTEIN; TRANSCRIPTION FACTOR;

ADIPOGENESIS; BILE ACID METABOLISM; CATABOLISM; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CHOLESTEROL METABOLISM; DIMERIZATION; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; GENE CONTROL; GENE EXPRESSION; GLUCOSE METABOLISM; HOMEOSTASIS; HORMONE ACTION; HUMAN; INFLAMMATION; LIPID METABOLISM; LIPID STORAGE; METABOLIC REGULATION; NONHUMAN; OSTEOBLAST; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TISSUE REPAIR; TRANSCRIPTION INITIATION; UBIQUITINATION;

ANIMALS; CELL PHYSIOLOGY; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; LIPID METABOLISM; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 32644460092     PISSN: 01637827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plipres.2005.12.002     Document Type: Review

References (338)

1. Nuclear Receptor Nomenclature Committee A unified nomenclature system for the nuclear receptor superfamily Cell 97 1999 161 163
2. I. Issemann, and S. Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 347 1990 645 650
3. C. Dreyer, G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors Cell 68 1992 879 887
4. P. Escher, and W. Wahli Peroxisome proliferator-activated receptors: insight into multiple cellular functions Mutat Res 448 2000 121 138
5. G. Krey, O. Braissant, F. L'Horset, E. Kalkhoven, M. Perroud, and M.G. Parker Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay Mol Endocrinol 11 1997 779 791
6. J. Berger, and D.E. Moller The mechanisms of action of PPARs Annu Rev Med 53 2002 409 435
7. H.A. Hostetler, A.D. Petrescu, A.B. Kier, and F. Schroeder Peroxisome proliferator-activated receptor alpha interacts with high affinity and is conformationally responsive to endogenous ligands J Biol Chem 280 2005 18667 18682
8. F.J. Schopfer, Y. Lin, P.R. Baker, T. Cui, M. Garcia-Barrio, and J. Zhang Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand Proc Natl Acad Sci USA 102 2005 2340 2345
9. T. Shiraki, N. Kamiya, S. Shiki, T.S. Kodama, A. Kakizuka, and H. Jingami Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma J Biol Chem 280 2005 14145 14153
10. C. Wolfrum, C.M. Borrmann, T. Borchers, and F. Spener Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus Proc Natl Acad Sci USA 98 2001 2323 2328
11. N.S. Tan, N.S. Shaw, N. Vinckenbosch, P. Liu, R. Yasmin, and B. Desvergne Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription Mol Cell Biol 22 2002 5114 5127
12. R.T. Nolte, G.B. Wisely, S. Westin, J.E. Cobb, M.H. Lambert, and R. Kurokawa Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma Nature 395 1998 137 143
13. D. Moras, and H. Gronemeyer The nuclear receptor ligand-binding domain: structure and function Curr Opin Cell Biol 10 1998 384 391
14. M. Togashi, S. Borngraeber, B. Sandler, R.J. Fletterick, P. Webb, and J.D. Baxter Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design J Steroid Biochem Mol Biol 93 2005 127 137
15. H.E. Xu, M.H. Lambert, V.G. Montana, D.J. Parks, S.G. Blanchard, and P.J. Brown Molecular recognition of fatty acids by peroxisome proliferator-activated receptors Mol Cell 3 1999 397 403
16. F. Molnar, M. Matilainen, and C. Carlberg Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators J Biol Chem 280 2005 26543 26556
17. B.C. Kallenberger, J.D. Love, V.K. Chatterjee, and J.W. Schwabe A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease Nat Struct Biol 10 2003 136 140
18. H. Keller, C. Dreyer, J. Medin, A. Mahfoudi, K. Ozato, and W. Wahli Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers Proc Natl Acad Sci USA 90 1993 2160 2164
19. K.L. Gearing, M. Gottlicher, M. Teboul, E. Widmark, and J.A. Gustafsson Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor Proc Natl Acad Sci USA 90 1993 1440 1444
20. C. Juge-Aubry, A. Pernin, T. Favez, A.G. Burger, W. Wahli, and C.A. Meier DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region J Biol Chem 272 1997 25252 25259
21. J.N. Feige, L. Gelman, C. Tudor, Y. Engelborghs, W. Wahli, and B. Desvergne Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand J Biol Chem 280 2005 17880 17890
22. C.N. Palmer, M.H. Hsu, H.J. Griffin, and E.F. Johnson Novel sequence determinants in peroxisome proliferator signaling J Biol Chem 270 1995 16114 16121
23. A. IJpenberg, E. Jeannin, W. Wahli, and B. Desvergne Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element J Biol Chem 272 1997 20108 20117
24. B.M. Forman, J. Chen, and R.M. Evans Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta Proc Natl Acad Sci USA 94 1997 4312 4317
25. T.C. He, T.A. Chan, B. Vogelstein, and K.W. Kinzler PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs Cell 99 1999 335 345
26. H.P. Guan, T. Ishizuka, P.C. Chui, M. Lehrke, and M.A. Lazar Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes Genes Dev 19 2005 453 461
27. P.C. Chui, H.P. Guan, M. Lehrke, and M.A. Lazar PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1 J Clin Invest 2005
28. M. Fu, M. Rao, T. Bouras, C. Wang, K. Wu, and X. Zhang Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment J Biol Chem 280 2005 16934 16941
29. E. Seree, P.H. Villard, J.M. Pascussi, T. Pineau, P. Maurel, and Q.B. Nguyen Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites Gastroenterology 127 2004 1436 1445
30. M. Shimizu, A. Takeshita, T. Tsukamoto, F.J. Gonzalez, and T. Osumi Tissue-selective, bidirectional regulation of PEX11 alpha and perilipin genes through a common peroxisome proliferator response element Mol Cell Biol 24 2004 1313 1323
31. A. IJpenberg, N.S. Tan, L. Gelman, S. Kersten, J. Seydoux, and J. Xu In vivo activation of PPAR target genes by RXR homodimers EMBO J 23 2004 2083 2091
32. S. Mandard, F. Zandbergen, N.S. Tan, P. Escher, D. Patsouris, and W. Koenig The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment J Biol Chem 279 2004 34411 34420
33. Y. Jia, C. Qi, P. Kashireddi, S. Surapureddi, Y.J. Zhu, and M.S. Rao Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver J Biol Chem 279 2004 24427 24434
34. E. Compe, P. Drane, C. Laurent, K. Diderich, C. Braun, and J.H. Hoeijmakers Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations Mol Cell Biol 25 2005 6065 6076
35. G. Pascual, A.L. Fong, S. Ogawa, A. Gamliel, A.C. Li, and V. Perissi A sumoylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma Nature 1 2005
36. F. Gizard, C. Amant, O. Barbier, S. Bellosta, R. Robillard, and F. Percevault PPARalpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16 J Clin Invest 2005
37. S.A. Kliewer, K. Umesono, D.J. Noonan, R.A. Heyman, and R.M. Evans Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 358 1992 771 774
38. I. Issemann, R.A. Prince, J.D. Tugwood, and S. Green The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs J Mol Endocrinol 11 1993 37 47
39. R. Mukherjee, P.J. Davies, D.L. Crombie, E.D. Bischoff, R.M. Cesario, and L. Jow Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists Nature 386 1997 407 410
40. I.G. Schulman, G. Shao, and R.A. Heyman Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function Mol Cell Biol 18 1998 3483 3494
41. M. Gurnell, J.M. Wentworth, M. Agostini, M. Adams, T.N. Collingwood, and C. Provenzano A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis J Biol Chem 275 2000 5754 5759
42. C.E. Juge-Aubry, E. Hammar, C. Siegrist-Kaiser, A. Pernin, A. Takeshita, and W.W. Chin Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain J Biol Chem 274 1999 10505 10510
43. M. Adams, M.J. Reginato, D. Shao, M.A. Lazar, and V.K. Chatterjee Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site J Biol Chem 272 1997 5128 5132
44. A. Werman, A. Hollenberg, G. Solanes, C. Bjorbaek, A.J. Vidal-Puig, and J.S. Flier Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin J Biol Chem 272 1997 20230 20235
45. R. Hi, S. Osada, N. Yumoto, and T. Osumi Characterization of the amino-terminal activation domain of peroxisome proliferator-activated receptor alpha. Importance of alpha-helical structure in the transactivating function J Biol Chem 274 1999 35152 35158
46. L. Gelman, G. Zhou, L. Fajas, E. Raspe, J.C. Fruchart, and J. Auwerx p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively J Biol Chem 274 1999 7681 7688
47. L. Gelman, M. Michalik, B. Desvergne, and W. Wahli Kinase signaling cascades that modulate PPARs Curr Opin Cell Biol (review) 2005
48. G. Lazennec, L. Canaple, D. Saugy, and W. Wahli Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators Mol Endocrinol 14 2000 1962 1975
49. P. Tontonoz, E. Hu, and B.M. Spiegelman Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor Cell 79 1994 1147 1156
50. B. Mascrez, M. Mark, W. Krezel, V. Dupe, M. LeMeur, and N.B. Ghyselinck Differential contributions of AF-1 and AF-2 activities to the developmental functions of RXR alpha Development 128 2001 2049 2062
51. R.X. Xu, M.H. Lambert, B.B. Wisely, E.N. Warren, E.E. Weinert, and G.M. Waitt A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer Mol Cell 16 2004 919 928
52. C. Frank, F. Molnar, M. Matilainen, H. Lempiainen, and C. Carlberg Agonist-dependent and agonist-independent transactivations of the human constitutive androstane receptor are modulated by specific amino acid pairs J Biol Chem 279 2004 33558 33566
53. X.Y. Yang, L.H. Wang, T. Chen, D.R. Hodge, J.H. Resau, and L. DaSilva Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT J Biol Chem 275 2000 4541 4544
54. L.H. Wang, X.Y. Yang, X. Zhang, J. Huang, J. Hou, and J. Li Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells Immunity 20 2004 205 218
55. A. Mouthiers, A. Baillet, C. Delomenie, D. Porquet, and N. Mejdoubi-Charef Peroxisome proliferator-activated receptor alpha physically interacts with CCAAT/enhancer binding protein (C/EBPbeta) to inhibit C/EBPbeta-responsive alpha1-acid glycoprotein gene expression Mol Endocrinol 19 2005 1135 1146
56. P. Delerive, K. De Bosscher, S. Besnard, W. Vanden Berghe, J.M. Peters, and F.J. Gonzalez Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1 J Biol Chem 274 1999 32048 32054
57. B. Staels, W. Koenig, A. Habib, R. Merval, M. Lebret, and I.P. Torra Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators Nature 393 1998 790 793
58. S.W. Chung, B.Y. Kang, S.H. Kim, Y.K. Pak, D. Cho, and G. Trinchieri Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B J Biol Chem 275 2000 32681 32687
59. D. Kelly, J.I. Campbell, T.P. King, G. Grant, E.A. Jansson, and A.G. Coutts Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA Nat Immunol 5 2004 104 112
60. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
61. M. Li, G. Pascual, and C.K. Glass Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene Mol Cell Biol 20 2000 4699 4707
62. C. Wang, M. Fu, M. D'Amico, C. Albanese, J.N. Zhou, and M. Brownlee Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1 Mol Cell Biol 21 2001 3057 3070
63. P. Gervois, N. Vu-Dac, R. Kleemann, M. Kockx, G. Dubois, and B. Laine Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta J Biol Chem 276 2001 33471 33477
64. C.H. Lee, A. Chawla, N. Urbiztondo, D. Liao, W.A. Boisvert, and R.M. Evans Transcriptional repression of atherogenic inflammation: modulation by PPARdelta Science 302 2003 453 457
65. C. Diradourian, J. Girard, and J.P. Pegorier Phosphorylation of PPARs: from molecular characterization to physiological relevance Biochimie 87 2005 33 38
66. D. Shao, S.M. Rangwala, S.T. Bailey, S.L. Krakow, M.J. Reginato, and M.A. Lazar Interdomain communication regulating ligand binding by PPAR-gamma Nature 396 1998 377 380
67. E. Hu, J.B. Kim, P. Sarraf, and B.M. Spiegelman Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma Science 274 1996 2100 2103
68. J.P. Gray, K.A. Burns, T.L. Leas, G.H. Perdew, and J.P. Vanden Heuvel Regulation of peroxisome proliferator-activated receptor alpha by protein kinase C Biochemistry 44 2005 10313 10321
69. P. Dowell, J.E. Ishmael, D. Avram, V.J. Peterson, D.J. Nevrivy, and M. Leid Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein J Biol Chem 274 1999 15901 15907
70. P.M. Barger, A.C. Browning, A.N. Garner, and D.P. Kelly p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response J Biol Chem 276 2001 44495 44501
71. R.B. Vega, J.M. Huss, and D.P. Kelly The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes Mol Cell Biol 20 2000 1868 1876
72. N.S. Yaacob, M.N. Norazmi, G.G. Gibson, and G.E. Kass The transcription of the peroxisome proliferator-activated receptor alpha gene is regulated by protein kinase C Toxicol Lett 125 2001 133 141
73. N.S. Tan, L. Michalik, N. Noy, R. Yasmin, C. Pacot, and M. Heim Critical roles of PPAR beta/delta in keratinocyte response to inflammation Genes Dev 15 2001 3263 3277
74. C. Solomon, J.H. White, and R. Kremer Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid X receptor alpha J Clin Invest 103 1999 1729 1735
75. P. Puigserver, J. Rhee, J. Lin, Z. Wu, J.C. Yoon, and C.Y. Zhang Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1 Mol Cell 8 2001 971 982
76. D. Knutti, D. Kressler, and A. Kralli Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor Proc Natl Acad Sci USA 98 2001 9713 9718
77. P. Misra, E.D. Owuor, W. Li, S. Yu, C. Qi, and K. Meyer Phosphorylation of transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP). Stimulation of transcriptional regulation by mitogen-activated protein kinase J Biol Chem 277 2002 48745 48754
78. B.G. Rowan, N.L. Weigel, and B.W. O'Malley Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway J Biol Chem 275 2000 4475 4483
79. G.N. Lopez, C.W. Turck, F. Schaufele, M.R. Stallcup, and P.J. Kushner Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity J Biol Chem 276 2001 22177 22182
80. O. Hermanson, K. Jepsen, and M.G. Rosenfeld N-CoR controls differentiation of neural stem cells into astrocytes Nature 419 2002 934 939
81. B.A. Jonas, and M.L. Privalsky SMRT and N-CoR corepressors are regulated by distinct kinase signaling pathways J Biol Chem 2004
82. B. Zhang, J. Berger, G. Zhou, A. Elbrecht, S. Biswas, and S. White-Carrington Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma J Biol Chem 271 1996 31771 31774
83. S.M. Rangwala, B. Rhoades, J.S. Shapiro, A.S. Rich, J.K. Kim, and G.I. Shulman Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity Dev Cell 5 2003 657 663
84. N. Kubota, Y. Terauchi, H. Miki, H. Tamemoto, T. Yamauchi, and K. Komeda PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance Mol Cell 4 1999 597 609
85. J. Rieusset, F. Touri, L. Michalik, P. Escher, B. Desvergne, and E. Niesor A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity Mol Endocrinol 16 2002 2628 2644
86. A. Hershko, and A. Ciechanover The ubiquitin system Annu Rev Biochem 67 1998 425 479
87. A.P. Dennis, and B.W. O'Malley Rush hour at the promoter: how the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription J Steroid Biochem Mol Biol 93 2005 139 151
88. G. Reid, M.R. Hubner, R. Metivier, H. Brand, S. Denger, and D. Manu Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling Mol Cell 11 2003 695 707
89. S. Hauser, G. Adelmant, P. Sarraf, H.M. Wright, E. Mueller, and B.M. Spiegelman Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation J Biol Chem 275 2000 18527 18533
90. C. Blanquart, O. Barbier, J.C. Fruchart, B. Staels, and C. Glineur Peroxisome proliferator-activated receptor alpha (PPARalpha) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes J Biol Chem 277 2002 37254 37259
91. M. Hirotani, T. Tsukamoto, J. Bourdeaux, H. Sadano, and T. Osumi Stabilization of peroxisome proliferator-activated receptor alpha by the ligand Biochem Biophys Res Commun 288 2001 106 110
92. S.R. Grossman, M.E. Deato, C. Brignone, H.M. Chan, A.L. Kung, and H. Tagami Polyubiquitination of p53 by a ubiquitin ligase activity of p300 Science 300 2003 342 344
93. Z.E. Floyd, and J.M. Stephens Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes J Biol Chem 277 2002 4062 4068
94. W.C. Tsao, H.M. Wu, K.H. Chi, Y.H. Chang, and W.W. Lin Proteasome inhibitors induce peroxisome proliferator-activated receptor transactivation through RXR accumulation and a protein kinase C-dependent pathway Exp Cell Res 304 2005 234 243
95. D.J. Kim, T.E. Akiyama, F.S. Harman, A.M. Burns, W. Shan, and J.M. Ward Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis J Biol Chem 279 2004 23719 23727
96. R.T. Hay SUMO: a history of modification Mol Cell 18 2005 1 12
97. T. Ohshima, H. Koga, and K. Shimotohno Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification J Biol Chem 279 2004 29551 29557
98. D. Yamashita, T. Yamaguchi, M. Shimizu, N. Nakata, F. Hirose, and T. Osumi The transactivating function of peroxisome proliferator-activated receptor gamma is negatively regulated by SUMO conjugation in the amino-terminal domain Genes Cells 9 2004 1017 1029
99. N. Kotaja, S. Aittomaki, O. Silvennoinen, J.J. Palvimo, and O.A. Janne ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation Mol Endocrinol 14 2000 1986 2000
100. G. Gill SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev 18 2004 2046 2059
101. P.B. Hebbar, and T.K. Archer Chromatin remodeling by nuclear receptors Chromosoma 111 2003 495 504
102. D. Robyr, A.P. Wolffe, and W. Wahli Nuclear hormone receptor coregulators in action: diversity for shared tasks Mol Endocrinol 14 2000 329 347
103. N.J. McKenna, and B.W. O'Malley Combinatorial control of gene expression by nuclear receptors and coregulators Cell 108 2002 465 474
104. A.J. Horlein, A.M. Naar, T. Heinzel, J. Torchia, B. Gloss, and R. Kurokawa Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor Nature 377 1995 397 404
105. J.D. Chen, and R.M. Evans A transcriptional co-repressor that interacts with nuclear hormone receptors Nature 377 1995 454 457
106. G.E. Muscat, L.J. Burke, and M. Downes The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70 Nucleic Acids Res 26 1998 2899 2907
107. X. Hu, Y. Li, and M.A. Lazar Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors Mol Cell Biol 21 2001 1747 1758
108. A.M. Krogsdam, C.A. Nielsen, S. Neve, D. Holst, T. Helledie, and B. Thomsen Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation Biochem J 363 2002 157 165
109. T.B. Stanley, L.M. Leesnitzer, V.G. Montana, C.M. Galardi, M.H. Lambert, and J.A. Holt Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity Biochemistry 42 2003 9278 9287
110. C. Yu, K. Markan, K.A. Temple, D. Deplewski, M.J. Brady, and R.N. Cohen The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis J Biol Chem 280 2005 13600 13605
111. I. Zamir, J. Zhang, and M.A. Lazar Stoichiometric and steric principles governing repression by nuclear hormone receptors Genes Dev 11 1997 835 846
112. F. Picard, M. Kurtev, N. Chung, A. Topark-Ngarm, T. Senawong, and R. Machado De Oliveira Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma Nature 429 2004 771 776
113. J.H. Hong, E.S. Hwang, M.T. McManus, A. Amsterdam, Y. Tian, and R. Kalmukova TAZ, a transcriptional modulator of mesenchymal stem cell differentiation Science 309 2005 1074 1078
114. Y. Shi, M. Hon, and R.M. Evans The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling Proc Natl Acad Sci USA 99 2002 2613 2618
115. H.E. Xu, T.B. Stanley, V.G. Montana, M.H. Lambert, B.G. Shearer, and J.E. Cobb Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha Nature 415 2002 813 817
116. J.H. White, I. Fernandes, S. Mader, and X.J. Yang Corepressor recruitment by agonist-bound nuclear receptors Vitam Horm 68 2004 123 143
117. E. Treuter, T. Albrektsen, L. Johansson, J. Leers, and J.A. Gustafsson A regulatory role for RIP140 in nuclear receptor activation Mol Endocrinol 12 1998 864 881
118. K.S. Miyata, S.E. McCaw, L.M. Meertens, H.V. Patel, R.A. Rachubinski, and J.P. Capone Receptor-interacting protein 140 interacts with and inhibits transactivation by, peroxisome proliferator-activated receptor alpha and liver-X-receptor alpha Mol Cell Endocrinol 146 1998 69 76
119. G. Leonardsson, J.H. Steel, M. Christian, V. Pocock, S. Milligan, and J. Bell Nuclear receptor corepressor RIP140 regulates fat accumulation Proc Natl Acad Sci USA 101 2004 8437 8442
120. L. Fajas, V. Egler, R. Reiter, J. Hansen, K. Kristiansen, and M.B. Debril The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation Dev Cell 3 2002 903 910
121. A.M. Flores, L. Li, and B.J. Aneskievich Isolation and functional analysis of a keratinocyte-derived, ligand-regulated nuclear receptor comodulator J Invest Dermatol 123 2004 1092 1101
122. I. Fernandes, Y. Bastien, T. Wai, K. Nygard, R. Lin, and O. Cormier Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms Mol Cell 11 2003 139 150
123. V. Perissi, and M.G. Rosenfeld Controlling nuclear receptors: the circular logic of cofactor cycles Nat Rev Mol Cell Biol 6 2005 542 554
124. V. Perissi, A. Aggarwal, C.K. Glass, D.W. Rose, and M.G. Rosenfeld A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors Cell 116 2004 511 526
125. J.A. Martens, and F. Winston Recent advances in understanding chromatin remodeling by Swi/Snf complexes Curr Opin Genet Dev 13 2003 136 142
126. B. Lemon, C. Inouye, D.S. King, and R. Tjian Selectivity of chromatin-remodelling cofactors for ligand-activated transcription Nature 414 2001 924 928
127. M.B. Debril, L. Gelman, E. Fayard, J.S. Annicotte, S. Rocchi, and J. Auwerx Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit J Biol Chem 279 2004 16677 16686
128. N. Salma, H. Xiao, E. Mueller, and A.N. Imbalzano Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor gamma nuclear hormone receptor Mol Cell Biol 24 2004 4651 4663
129. S. Surapureddi, S. Yu, H. Bu, T. Hashimoto, A.V. Yeldandi, and P. Kashireddy Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator Proc Natl Acad Sci USA 99 2002 11836 11841
130. T. Jenuwein, and C.D. Allis Translating the histone code Science 293 2001 1074 1080
131. A. Imhof Histone modifications: an assembly line for active chromatin? Curr Biol 13 2003 R22 R24
132. E. Kalkhoven CBP and p300: HATs for different occasions Biochem Pharmacol 68 2004 1145 1155
133. P. Dowell, J.E. Ishmael, D. Avram, V.J. Peterson, D.J. Nevrivy, and M. Leid p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha J Biol Chem 272 1997 33435 33443
134. F.A. Klein, R.A. Atkinson, N. Potier, D. Moras, and J. Cavarelli Biochemical and NMR mapping of the interface between CREB-binding protein and ligand binding domains of nuclear receptor: beyond the LXXLL motif J Biol Chem 280 2005 5682 5692
135. T. Yamauchi, Y. Oike, J. Kamon, H. Waki, K. Komeda, and A. Tsuchida Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice Nat Genet 30 2002 221 226
136. G. Zhou, R. Cummings, Y. Li, S. Mitra, H.A. Wilkinson, and A. Elbrecht Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer Mol Endocrinol 12 1998 1594 1604
137. R. Mukherjee, S. Sun, L. Santomenna, B. Miao, H. Walton, and B. Liao Ligand and coactivator recruitment preferences of peroxisome proliferator activated receptor alpha J Steroid Biochem Mol Biol 81 2002 217 225
138. T.E. Spencer, G. Jenster, M.M. Burcin, C.D. Allis, J. Zhou, and C.A. Mizzen Steroid receptor coactivator-1 is a histone acetyltransferase Nature 389 1997 194 198
139. H. Chen, R.J. Lin, R.L. Schiltz, D. Chakravarti, A. Nash, and L. Nagy Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 Cell 90 1997 569 580
140. J. DiRenzo, M. Soderstrom, R. Kurokawa, M.H. Ogliastro, M. Ricote, and S. Ingrey Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors Mol Cell Biol 17 1997 2166 2176
141. F. Picard, M. Gehin, J. Annicotte, S. Rocchi, M.F. Champy, and B.W. O'Malley SRC-1 and TIF2 control energy balance between white and brown adipose tissues Cell 111 2002 931 941
142. C. Qi, Y. Zhu, J. Pan, A.V. Yeldandi, M.S. Rao, and N. Maeda Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor alpha-regulated gene expression Proc Natl Acad Sci USA 96 1999 1585 1590
143. J. Xu, and Q. Li Review of the in vivo functions of the p160 steroid receptor coactivator family Mol Endocrinol 17 2003 1681 1692
144. W. Yang, C. Rachez, and L.P. Freedman Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators Mol Cell Biol 20 2000 8008 8017
145. D. Chen, H. Ma, H. Hong, S.S. Koh, S.M. Huang, and B.T. Schurter Regulation of transcription by a protein methyltransferase Science 284 1999 2174 2177
146. S.S. Koh, D. Chen, Y.H. Lee, and M.R. Stallcup Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities J Biol Chem 276 2001 1089 1098
147. H. Wang, Z.Q. Huang, L. Xia, Q. Feng, H. Erdjument-Bromage, and B.D. Strahl Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor Science 293 2001 853 857
148. C. Qi, J. Chang, Y. Zhu, A.V. Yeldandi, S.M. Rao, and Y.J. Zhu Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha J Biol Chem 277 2002 28624 28630
149. Y. Shi, F. Lan, C. Matson, P. Mulligan, J.R. Whetstine, and P.A. Cole Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 Cell 119 2004 941 953
150. E. Metzger, M. Wissmann, N. Yin, J.M. Muller, R. Schneider, and A.H. Peters LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription Nature 2005
151. P. Puigserver, G. Adelmant, Z. Wu, M. Fan, J. Xu, and B. O'Malley Activation of PPARgamma coactivator-1 through transcription factor docking Science 286 1999 1368 1371
152. M. Monsalve, Z. Wu, G. Adelmant, P. Puigserver, M. Fan, and B.M. Spiegelman Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1 Mol Cell 6 2000 307 316
153. Y.X. Wang, C.H. Lee, S. Tiep, R.T. Yu, J. Ham, and H. Kang Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity Cell 113 2003 159 170
154. P. Puigserver, Z. Wu, C.W. Park, R. Graves, M. Wright, and B.M. Spiegelman A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis Cell 92 1998 829 839
155. Y. Wu, W.W. Chin, Y. Wang, and T.P. Burris Ligand and coactivator identity determines the requirement of the charge clamp for coactivation of the peroxisome proliferator-activated receptor gamma J Biol Chem 278 2003 8637 8644
156. H. Oberkofler, H. Esterbauer, V. Linnemayr, A.D. Strosberg, F. Krempler, and W. Patsch Peroxisome proliferator-activated receptor (PPAR) gamma coactivator-1 recruitment regulates PPAR subtype specificity J Biol Chem 277 2002 16750 16757
157. P. Puigserver, and B.M. Spiegelman Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator Endocr Rev 24 2003 78 90
158. J. Lin, C. Handschin, and B.M. Spiegelman Metabolic control through the PGC-1 family of transcription coactivators Cell Metab 1 2005 361 370
159. Y. Zhu, L. Kan, C. Qi, Y.S. Kanwar, A.V. Yeldandi, and M.S. Rao Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR J Biol Chem 275 2000 13510 13516
160. Y. Zhu, C. Qi, W.Q. Cao, A.V. Yeldandi, M.S. Rao, and J.K. Reddy Cloning and characterization of PIMT, a protein with a methyltransferase domain, which interacts with and enhances nuclear receptor coactivator PRIP function Proc Natl Acad Sci USA 98 2001 10380 10385
161. Y.J. Zhu, S.E. Crawford, V. Stellmach, R.S. Dwivedi, M.S. Rao, and F.J. Gonzalez Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development J Biol Chem 278 2003 1986 1990
162. P. Antonson, G.U. Schuster, L. Wang, B. Rozell, E. Holter, and P. Flodby Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction Mol Cell Biol 23 2003 1260 1268
163. C. Qi, S. Surapureddi, Y.J. Zhu, S. Yu, P. Kashireddy, and M.S. Rao Transcriptional coactivator PRIP, the peroxisome proliferator-activated receptor gamma (PPARgamma)-interacting protein, is required for PPARgamma-mediated adipogenesis J Biol Chem 278 2003 25281 25284
164. B.A. Lewis, and D. Reinberg The mediator coactivator complex: functional and physical roles in transcriptional regulation J Cell Sci 116 2003 3667 3675
165. R.G. Roeder Transcriptional regulation and the role of diverse coactivators in animal cells FEBS Lett 579 2005 909 915
166. Y. Zhu, C. Qi, S. Jain, M.S. Rao, and J.K. Reddy Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor J Biol Chem 272 1997 25500 25506
167. C.X. Yuan, M. Ito, J.D. Fondell, Z.Y. Fu, and R.G. Roeder The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion Proc Natl Acad Sci USA 95 1998 7939 7944
168. C. Rachez, B.D. Lemon, Z. Suldan, V. Bromleigh, M. Gamble, and A.M. Naar Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex Nature 398 1999 824 828
169. S. Malik, M. Guermah, C.X. Yuan, W. Wu, S. Yamamura, and R.G. Roeder Structural and functional organization of TRAP220, the TRAP/mediator subunit that is targeted by nuclear receptors Mol Cell Biol 24 2004 8244 8254
170. X. Zhang, A. Krutchinsky, A. Fukuda, W. Chen, S. Yamamura, and B.T. Chait MED1/TRAP220 exists predominantly in a TRAP/mediator subpopulation enriched in rna polymerase II and is required for ER-mediated transcription Mol Cell 19 2005 89 100
171. M. Ito, C.X. Yuan, H.J. Okano, R.B. Darnell, and R.G. Roeder Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action Mol Cell 5 2000 683 693
172. Y. Zhu, C. Qi, Y. Jia, J.S. Nye, M.S. Rao, and J.K. Reddy Deletion of PBP/PPARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality J Biol Chem 275 2000 14779 14782
173. S.E. Crawford, C. Qi, P. Misra, V. Stellmach, M.S. Rao, and J.D. Engel Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors J Biol Chem 277 2002 3585 3592
174. K. Ge, M. Guermah, C.X. Yuan, M. Ito, A.E. Wallberg, and B.M. Spiegelman Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis Nature 417 2002 563 567
175. E.S. Tien, J.W. Davis, and J.P. Vanden Heuvel Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator J Biol Chem 279 2004 24053 24063
176. W. Shao, S. Halachmi, and M. Brown ERAP140, a conserved tissue-specific nuclear receptor coactivator Mol Cell Biol 22 2002 3358 3372
177. C.A. Heinlein, H.J. Ting, S. Yeh, and C. Chang Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma J Biol Chem 274 1999 16147 16152
178. A.E. Wallberg, S. Yamamura, S. Malik, B.M. Spiegelman, and R.G. Roeder Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha Mol Cell 12 2003 1137 1149
179. L. Ko, G.R. Cardona, and W.W. Chin Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator Proc Natl Acad Sci USA 97 2000 6212 6217
180. P. Misra, C. Qi, S. Yu, S.H. Shah, W.Q. Cao, and M.S. Rao Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation J Biol Chem 277 2002 20011 20019
181. B.M. Spiegelman, and R. Heinrich Biological control through regulated transcriptional coactivators Cell 119 2004 157 167
182. A.R. Kornblihtt, M. de la Mata, J.P. Fededa, M.J. Munoz, and G. Nogues Multiple links between transcription and splicing RNA 10 2004 1489 1498
183. D. Auboeuf, D.H. Dowhan, M. Dutertre, N. Martin, S.M. Berget, and B.W. O'Malley A subset of nuclear receptor coregulators act as coupling proteins during synthesis and maturation of RNA transcripts Mol Cell Biol 25 2005 5307 5316
184. N. Ohkura, M. Takahashi, H. Yaguchi, Y. Nagamura, and T. Tsukada Coactivator-associated arginine methyltransferase 1, CARM1, affects pre-mRNA splicing in an isoform-specific manner J Biol Chem 280 2005 28927 28935
185. J.P. Berger, T.E. Akiyama, and P.T. Meinke PPARs: therapeutic targets for metabolic disease Trends Pharmacol Sci 26 2005 244 251
186. J.S. Lewis, and V.C. Jordan Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance Mutat Res 591 2005 247 263
187. S. Rocchi, F. Picard, J. Vamecq, L. Gelman, N. Potier, and D. Zeyer A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity Mol Cell 8 2001 737 747
188. J.P. Berger, A.E. Petro, K.L. Macnaul, L.J. Kelly, B.B. Zhang, and K. Richards Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator Mol Endocrinol 17 2003 662 676
189. K. Liu, R.M. Black, J.J. Acton III, R. Mosley, S. Debenham, and R. Abola Selective PPARgamma modulators with improved pharmacological profiles Bioorg Med Chem Lett 15 2005 2437 2440
190. J.J. Acton III, R.M. Black, A.B. Jones, D.E. Moller, L. Colwell, and T.W. Doebber Benzoyl 2-methyl indoles as selective PPARgamma modulators Bioorg Med Chem Lett 15 2005 357 362
191. A. Shimaya, E. Kurosaki, R. Nakano, R. Hirayama, M. Shibasaki, and H. Shikama The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice Metabolism 49 2000 411 417
192. E. Kurosaki, R. Nakano, A. Shimaya, S. Yoshida, M. Ida, and T. Suzuki Differential effects of YM440 a hypoglycemic agent on binding to a peroxisome proliferator-activated receptor gamma and its transactivation Biochem Pharmacol 65 2003 795 805
193. R.N. Day, and F. Schaufele Imaging molecular interactions in living cells Mol Endocrinol 19 2005 1675 1686
194. R.D. Phair, and T. Misteli High mobility of proteins in the mammalian cell nucleus Nature 404 2000 604 609
195. R.D. Phair, P. Scaffidi, C. Elbi, J. Vecerova, A. Dey, and K. Ozato Global nature of dynamic protein-chromatin interactions in vivo: three-dimensional genome scanning and dynamic interaction networks of chromatin proteins Mol Cell Biol 24 2004 6393 6402
196. J.G. McNally, W.G. Muller, D. Walker, R. Wolford, and G.L. Hager The glucocorticoid receptor: rapid exchange with regulatory sites in living cells Science 287 2000 1262 1265
197. A. Agresti, P. Scaffidi, A. Riva, V.R. Caiolfa, and M.E. Bianchi GR and HMGB1 interact only within chromatin and influence each other's residence time Mol Cell 18 2005 109 121
198. D.L. Stenoien, A.C. Nye, M.G. Mancini, K. Patel, M. Dutertre, and B.W. O'Malley Ligand-mediated assembly and real-time cellular dynamics of estrogen receptor alpha-coactivator complexes in living cells Mol Cell Biol 21 2001 4404 4412
199. Y. Shang, X. Hu, J. DiRenzo, M.A. Lazar, and M. Brown Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription Cell 103 2000 843 852
200. R. Metivier, G. Penot, M.R. Hubner, G. Reid, H. Brand, and M. Kos Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter Cell 115 2003 751 763
201. A.K. Nagaich, D.A. Walker, R. Wolford, and G.L. Hager Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling Mol Cell 14 2004 163 174
202. K. Schoonjans, J. Peinado-Onsurbe, A.M. Lefebvre, R.A. Heyman, M. Briggs, and S. Deeb PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene EMBO J 15 1996 5336 5348
203. G. Martin, K. Schoonjans, A.M. Lefebvre, B. Staels, and J. Auwerx Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators J Biol Chem 272 1997 28210 28217
204. N.R. Coe, A.J. Smith, B.I. Frohnert, P.A. Watkins, and D.A. Bernlohr The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase J Biol Chem 274 1999 36300 36304
205. N.H. Haunerland, and F. Spener Fatty acid-binding proteins - insights from genetic manipulations Prog Lipid Res 43 2004 328 349
206. S. Mandard, M. Muller, and S. Kersten Peroxisome proliferator-activated receptor alpha target genes Cell Mol Life Sci 61 2004 393 416
207. E. Bedu, W. Wahli, and B. Desvergne Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases Expert Opin Ther Targets 9 2005 861 873
208. K. Watanabe, H. Fujii, T. Takahashi, M. Kodama, Y. Aizawa, and Y. Ohta Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity J Biol Chem 275 2000 22293 22299
209. B.N. Finck, J.J. Lehman, T.C. Leone, M.J. Welch, M.J. Bennett, and A. Kovacs The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus J Clin Invest 109 2002 121 130
210. B.N. Finck, C. Bernal-Mizrachi, D.H. Han, T. Coleman, N. Sambandam, and L.L. LaRiviere A potential link between muscle peroxisome proliferator-activated receptor-alpha signaling and obesity-related diabetes Cell Metab 1 2005 133 144
211. S. Kersten, J. Seydoux, J.M. Peters, F.J. Gonzalez, B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting J Clin Invest 103 1999 1489 1498
212. T.C. Leone, C.J. Weinheimer, and D.P. Kelly A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders Proc Natl Acad Sci USA 96 1999 7473 7478
213. D. Patsouris, S. Mandard, P.J. Voshol, P. Escher, N.S. Tan, and L.M. Havekes PPARalpha governs glycerol metabolism J Clin Invest 114 2004 94 103
214. S. Luquet, J. Lopez-Soriano, D. Holst, A. Fredenrich, J. Melki, and M. Rassoulzadegan Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability FASEB J 17 2003 2299 2301
215. Y.X. Wang, C.L. Zhang, R.T. Yu, H.K. Cho, M.C. Nelson, and C.R. Bayuga-Ocampo Regulation of muscle fiber type and running endurance by PPARdelta PLoS Biol 2 2004 e294
216. L. Cheng, G. Ding, Q. Qin, Y. Huang, W. Lewis, and N. He Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy Nat Med 10 2004 1245 1250
217. Y. Barak, D. Liao, W. He, E.S. Ong, M.C. Nelson, and J.M. Olefsky Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer Proc Natl Acad Sci USA 99 2002 303 308
218. J.M. Way, W.W. Harrington, K.K. Brown, W.K. Gottschalk, S.S. Sundseth, and T.A. Mansfield Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues Endocrinology 142 2001 1269 1277
219. U. Riserus, G.D. Tan, B.A. Fielding, M.J. Neville, J. Currie, and D.B. Savage Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma Diabetes 54 2005 1379 1384
220. H.P. Guan, Y. Li, M.V. Jensen, C.B. Newgard, C.M. Steppan, and M.A. Lazar A futile metabolic cycle activated in adipocytes by antidiabetic agents Nat Med 8 2002 1122 1128
221. K.T. Dalen, K. Schoonjans, S.M. Ulven, M.S. Weedon-Fekjaer, T.G. Bentzen, and H. Koutnikova Adipose tissue expression of the lipid droplet-associating proteins S3-12 and perilipin is controlled by peroxisome proliferator-activated receptor-gamma Diabetes 53 2004 1243 1252
222. A. Chawla, C.H. Lee, Y. Barak, W. He, J. Rosenfeld, and D. Liao PPARdelta is a very low-density lipoprotein sensor in macrophages Proc Natl Acad Sci USA 100 2003 1268 1273
223. L. Michalik, B. Desvergne, and W. Wahli Peroxisome-proliferator-activated receptors and cancers: complex stories Nat Rev Cancer 4 2004 61 70
224. J.M. Peters, R.C. Cattley, and F.J. Gonzalez Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643 Carcinogenesis 18 1997 2029 2033
225. J.M. Peters, T. Aoyama, R.C. Cattley, U. Nobumitsu, T. Hashimoto, and F.J. Gonzalez Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver Carcinogenesis 19 1998 1989 1994
226. J.M. Peters, C. Cheung, and F.J. Gonzalez Peroxisome proliferator- activated receptor-alpha and liver cancer: where do we stand? J Mol Med 83 2005 774 785
227. J.E. Klaunig, M.A. Babich, K.P. Baetcke, J.C. Cook, J.C. Corton, and R.M. David PPARalpha agonist-induced rodent tumors: modes of action and human relevance Crit Rev Toxicol 33 2003 655 780
228. C. Cheung, T.E. Akiyama, J.M. Ward, C.J. Nicol, L. Feigenbaum, and C. Vinson Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha Cancer Res 64 2004 3849 3854
229. L. Michalik, B. Desvergne, N.S. Tan, S. Basu-Modak, P. Escher, and J. Rieusset Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice J Cell Biol 154 2001 799 814
230. J.M. Peters, S.S. Lee, W. Li, J.M. Ward, O. Gavrilova, and C. Everett Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta) Mol Cell Biol 20 2000 5119 5128
231. D.J. Kim, M.T. Bility, A.N. Billin, T.M. Willson, F.J. Gonzalez, and J.M. Peters PPARbeta/delta selectively induces differentiation and inhibits cell proliferation Cell Death Differ 2005
232. K. Hellemans, L. Michalik, A. Dittie, A. Knorr, K. Rombouts, and J. De Jong Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells Gastroenterology 124 2003 184 201
233. J. Zhang, M. Fu, X. Zhu, Y. Xiao, Y. Mou, and H. Zheng Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells J Biol Chem 277 2002 11505 11512
234. A.D. Burdick, D.J. Kim, M.A. Peraza, F.J. Gonzalez, and J.M. Peters The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation Cell Signal 2005
235. D.L. Feinstein, A. Spagnolo, C. Akar, G. Weinberg, P. Murphy, and V. Gavrilyuk Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? Biochem Pharmacol 70 2005 177 188
236. S. Theocharis, A. Margeli, P. Vielh, and G. Kouraklis Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators Cancer Treat Rev 30 2004 545 554
237. S. Altiok, M. Xu, and B.M. Spiegelman PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A Genes Dev 11 1997 1987 1998
238. R.F. Morrison, and S.R. Farmer Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis J Biol Chem 274 1999 17088 17097
239. C. Qin, R. Burghardt, R. Smith, M. Wormke, J. Stewart, and S. Safe Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells Cancer Res 63 2003 958 964
240. R.A. Gupta, J.A. Brockman, P. Sarraf, T.M. Willson, and R.N. DuBois Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells J Biol Chem 276 2001 29681 29687
241. R.A. Gupta, P. Sarraf, J.A. Brockman, S.B. Shappell, L.A. Raftery, and T.M. Willson Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22 J Biol Chem 278 2003 7431 7438
242. L. Patel, I. Pass, P. Coxon, C.P. Downes, S.A. Smith, and C.H. Macphee Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN Curr Biol 11 2001 764 768
243. K.S. Lee, S.J. Park, P.H. Hwang, H.K. Yi, C.H. Song, and O.H. Chai PPAR-gamma modulates allergic inflammation through up-regulation of PTEN FASEB J 19 2005 1033 1035
244. L. Fajas, V. Egler, R. Reiter, S. Miard, A.M. Lefebvre, and J. Auwerx PPARgamma controls cell proliferation and apoptosis in an RB-dependent manner Oncogene 22 2003 4186 4193
245. D. Shao, and M.A. Lazar Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation J Biol Chem 272 1997 21473 21478
246. S. Wakino, U. Kintscher, S. Kim, F. Yin, W.A. Hsueh, and R.E. Law Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1 → S transition in vascular smooth muscle cells J Biol Chem 275 2000 22435 22441
247. A.P. Heaney, M. Fernando, and S. Melmed PPAR-gamma receptor ligands: novel therapy for pituitary adenomas J Clin Invest 111 2003 1381 1388
248. F. Zandbergen, S. Mandard, P. Escher, N.S. Tan, D. Patsouris, and T. Jatkoe The G0/G1 switch gene 2 is a novel PPAR target gene Biochem J 2005
249. N. Di-Poi, N.S. Tan, L. Michalik, W. Wahli, and B. Desvergne Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway Mol Cell 10 2002 721 733
250. N. Di-Poi, C.Y. Ng, N.S. Tan, Z. Yang, B.A. Hemmings, and B. Desvergne Epithelium-mesenchyme interactions control the activity of peroxisome proliferator-activated receptor beta/delta during hair follicle development Mol Cell Biol 25 2005 1696 1712
251. E. Letavernier, J. Perez, E. Joye, A. Bellocq, B. Fouqueray, and J.P. Haymann Peroxisome proliferator-activated receptor {beta}/{delta} exerts a strong protection from ischemic acute renal failure J Am Soc Nephrol 16 2005 2395 2402
252. C.M. Hao, R. Redha, J. Morrow, and M.D. Breyer Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress J Biol Chem 277 2002 21341 21345
253. T. Hatae, M. Wada, C. Yokoyama, M. Shimonishi, and T. Tanabe Prostacyclin-dependent apoptosis mediated by PPAR delta J Biol Chem 276 2001 46260 46267
254. G.G. Chen, J.F. Lee, S.H. Wang, U.P. Chan, P.C. Ip, and W.Y. Lau Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer Life Sci 70 2002 2631 2646
255. Y. Barak, M.C. Nelson, E.S. Ong, Y.Z. Jones, P. Ruiz-Lozano, and K.R. Chien PPAR gamma is required for placental, cardiac, and adipose tissue development Mol Cell 4 1999 585 595
256. T. Shalom-Barak, J.M. Nicholas, Y. Wang, X. Zhang, E.S. Ong, and T.H. Young Peroxisome proliferator-activated receptor gamma controls Muc1 transcription in trophoblasts Mol Cell Biol 24 2004 10661 10669
257. A. Tarrade, K. Schoonjans, J. Guibourdenche, J.M. Bidart, M. Vidaud, and J. Auwerx PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation Endocrinology 142 2001 4504 4514
258. F. Varnat, L. Michalik, B. Desvergne, and W. Wahli PPARs: lipid sensors that regulate cell differentiation processes R. Brigelius-Flohe H.G. Joost Nutritional genomics 2006 Wiley-VCH Weinheim 117 131
259. A. Abella, P. Dubus, M. Malumbres, S.G. Rane, H. Kiyokawa, and A. Sicard Cdk4 promotes adipogenesis through PPARgamma activation Cell Metab 2 2005 239 249
260. E.D. Rosen, C.J. Walkey, P. Puigserver, and B.M. Spiegelman Transcriptional regulation of adipogenesis Genes Dev 14 2000 1293 1307
261. E. Hu, P. Tontonoz, and B.M. Spiegelman Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha Proc Natl Acad Sci USA 92 1995 9856 9860
262. E.D. Rosen, P. Sarraf, A.E. Troy, G. Bradwin, K. Moore, and D.S. Milstone PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro Mol Cell 4 1999 611 617
263. W. He, Y. Barak, A. Hevener, P. Olson, D. Liao, and J. Le Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle Proc Natl Acad Sci USA 100 2003 15712 15717
264. T. Imai, R. Takakuwa, S. Marchand, E. Dentz, J.M. Bornert, and N. Messaddeq Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse Proc Natl Acad Sci USA 101 2004 4543 4547
265. L. Fajas, R.L. Landsberg, Y. Huss-Garcia, C. Sardet, J.A. Lees, and J. Auwerx E2Fs regulate adipocyte differentiation Dev Cell 3 2002 39 49
266. K. Matsusue, J.M. Peters, and F.J. Gonzalez PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation FASEB J 18 2004 1477 1479
267. C. Bastie, S. Luquet, D. Holst, C. Jehl-Pietri, and P.A. Grimaldi Alterations of peroxisome proliferator-activated receptor delta activity affect fatty acid-controlled adipose differentiation J Biol Chem 275 2000 38768 38773
268. J.B. Hansen, H. Zhang, T.H. Rasmussen, R.K. Petersen, E.N. Flindt, and K. Kristiansen Peroxisome proliferator-activated receptor delta (PPARdelta)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling J Biol Chem 276 2001 3175 3182
269. L. Madsen, R.K. Petersen, and K. Kristiansen Regulation of adipocyte differentiation and function by polyunsaturated fatty acids Biochim Biophys Acta 1740 2005 266 286
270. T. Akune, S. Ohba, S. Kamekura, M. Yamaguchi, U.I. Chung, and N. Kubota PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors J Clin Invest 113 2004 846 855
271. B. Lecka-Czernik, I. Gubrij, E.J. Moerman, O. Kajkenova, D.A. Lipschitz, and S.C. Manolagas Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2 J Cell Biochem 74 1999 357 371
272. A.A. Ali, R.S. Weinstein, S.A. Stewart, A.M. Parfitt, S.C. Manolagas, and R.L. Jilka Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation Endocrinology 146 2005 1226 1235
273. L.G. Komuves, K. Hanley, A.M. Lefebvre, M.Q. Man, D.C. Ng, and D.D. Bikle Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo J Invest Dermatol 115 2000 353 360
274. M. Schmuth, C.M. Haqq, W.J. Cairns, J.C. Holder, S. Dorsam, and S. Chang Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes J Invest Dermatol 122 2004 971 983
275. M. Mao-Qiang, A.J. Fowler, M. Schmuth, P. Lau, S. Chang, and B.E. Brown Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation J Invest Dermatol 123 2004 305 312
276. N. Di-Poi, L. Michalik, B. Desvergne, and W. Wahli Functions of peroxisome proliferator-activated receptors (PPAR) in skin homeostasis Lipids 39 2004 1093 1099
277. R.L. Rosenfield, A. Kentsis, D. Deplewski, and N. Ciletti Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors J Invest Dermatol 112 1999 226 232
278. M.J. Kim, D. Deplewski, N. Ciletti, S. Michel, U. Reichert, and R.L. Rosenfield Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development Mol Genet Metab 74 2001 362 369
279. N.S. Tan, L. Michalik, N. Di-Poi, C.Y. Ng, N. Mermod, and A.B. Roberts Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression EMBO J 23 2004 4211 4221
280. N.S. Tan, L. Michalik, B. Desvergne, and W. Wahli Genetic- or transforming growth factor-beta1-induced changes in epidermal peroxisome proliferator-activated receptor beta/delta expression dictate wound repair kinetics J Biol Chem 280 2005 18163 18170
281. M. Lefebvre, B. Paulweber, L. Fajas, J. Woods, C. McCrary, and J.F. Colombel Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells J Endocrinol 162 1999 331 340
282. J.A. Brockman, R.A. Gupta, and R.N. Dubois Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells Gastroenterology 115 1998 1049 1055
283. P. Sarraf, E. Mueller, D. Jones, F.J. King, D.J. DeAngelo, and J.B. Partridge Differentiation and reversal of malignant changes in colon cancer through PPARgamma Nat Med 4 1998 1046 1052
284. R.A. Gupta, P. Sarraf, E. Mueller, J.A. Brockman, J.J. Prusakiewicz, and C. Eng Peroxisome proliferator-activated receptor gamma-mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms J Biol Chem 278 2003 22669 22677
285. P. Tontonoz, L. Nagy, J.G. Alvarez, V.A. Thomazy, and R.M. Evans PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL Cell 93 1998 241 252
286. A. Chawla, Y. Barak, L. Nagy, D. Liao, P. Tontonoz, and R.M. Evans PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation Nat Med 7 2001 48 52
287. O. Braissant, and W. Wahli Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development Endocrinology 139 1998 2748 2754
288. R. Kostadinova, W. Wahli, and L. Michalik PPARs in diseases: control mechanisms of inflammation Curr Med Chem 12 2005 2413 2446
289. P.R. Devchand, H. Keller, J.M. Peters, M. Vazquez, F.J. Gonzalez, and W. Wahli The PPARalpha-leukotriene B4 pathway to inflammation control Nature 384 1996 39 43
290. R. Kleemann, P.P. Gervois, L. Verschuren, B. Staels, H.M. Princen, and T. Kooistra Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation Blood 101 2003 545 551
291. M. Kockx, P.P. Gervois, P. Poulain, B. Derudas, J.M. Peters, and F.J. Gonzalez Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha Blood 93 1999 2991 2998
292. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
293. S. Ogawa, J. Lozach, C. Benner, G. Pascual, R.K. Tangirala, and S. Westin Molecular determinants of crosstalk between nuclear receptors and toll-like receptors Cell 122 2005 707 721
294. M. Lehrke, G. Pascual, C.K. Glass, and M.A. Lazar Gaining weight: the keystone symposium on PPAR and LXR Genes Dev 19 2005 1737 1742
295. T. Yoshikawa, T. Ide, H. Shimano, N. Yahagi, M. Amemiya-Kudo, and T. Matsuzaka Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling Mol Endocrinol 17 2003 1240 1254
296. T. Ide, H. Shimano, T. Yoshikawa, N. Yahagi, M. Amemiya-Kudo, and T. Matsuzaka Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling Mol Endocrinol 17 2003 1255 1267
297. J.J. Repa, G. Liang, J. Ou, Y. Bashmakov, J.M. Lobaccaro, and I. Shimomura Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta Genes Dev 14 2000 2819 2830
298. K.S. Miyata, S.E. McCaw, H.V. Patel, R.A. Rachubinski, and J.P. Capone The orphan nuclear hormone receptor LXR alpha interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling J Biol Chem 271 1996 9189 9192
299. Y. Zhang, L.W. Castellani, C.J. Sinal, F.J. Gonzalez, and P.A. Edwards Peroxisome proliferator-activated receptor-gamma coactivator1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR Genes Dev 18 2004 157 169
300. S. Fiorucci, G. Rizzo, E. Antonelli, B. Renga, A. Mencarelli, and L. Riccardi Crosstalk between farnesoid X-receptor (FXR) and peroxisome proliferator-activated receptor (PPAR) {gamma} contributes to the anti-fibrotic activity of FXR ligands in rodent models of liver cirrhosis J Pharmacol Exp Ther 2005
301. I. Pineda Torra, T. Claudel, C. Duval, V. Kosykh, J.C. Fruchart, and B. Staels Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor Mol Endocrinol 17 2003 259 272
302. Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiol Rev [in press].
303. G. Chinetti, S. Lestavel, V. Bocher, A.T. Remaley, B. Neve, and I.P. Torra PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat Med 7 2001 53 58
304. K.A. Tobin, H.H. Steineger, S. Alberti, O. Spydevold, J. Auwerx, and J.A. Gustafsson Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha Mol Endocrinol 14 2000 741 752
305. A. Chawla, W.A. Boisvert, C.H. Lee, B.A. Laffitte, Y. Barak, and S.B. Joseph A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis Mol Cell 7 2001 161 171
306. T.E. Akiyama, S. Sakai, G. Lambert, C.J. Nicol, K. Matsusue, and S. Pimprale Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux Mol Cell Biol 22 2002 2607 2619
307. A. Szanto, S. Benko, I. Szatmari, B.L. Balint, I. Furtos, and R. Ruhl Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages Mol Cell Biol 24 2004 8154 8166
308. A.C. Li, C.J. Binder, A. Gutierrez, K.K. Brown, C.R. Plotkin, and J.W. Pattison Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma J Clin Invest 114 2004 1564 1576
309. M. Marrapodi, and J.Y. Chiang Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription J Lipid Res 41 2000 514 520
310. S.M. Post, H. Duez, P.P. Gervois, B. Staels, F. Kuipers, and H.M. Princen Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression Arterioscler Thromb Vasc Biol 21 2001 1840 1845
311. B. Desvergne, L. Michalik, and W. Wahli Be fit or be sick: peroxisome proliferator-activated receptors are down the road Mol Endocrinol 18 2004 1321 1332
312. R.M. Evans, G.D. Barish, and Y.X. Wang PPARs and the complex journey to obesity Nat Med 10 2004 355 361
313. L. Chao, B. Marcus-Samuels, M.M. Mason, J. Moitra, C. Vinson, and E. Arioglu Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones J Clin Invest 106 2000 1221 1228
314. C.F. Burant, S. Sreenan, K. Hirano, T.A. Tai, J. Lohmiller, and J. Lukens Troglitazone action is independent of adipose tissue J Clin Invest 100 1997 2900 2908
315. A.L. Hevener, W. He, Y. Barak, J. Le, G. Bandyopadhyay, and P. Olson Muscle-specific Pparg deletion causes insulin resistance Nat Med 9 2003 1491 1497
316. A.W. Norris, L. Chen, S.J. Fisher, I. Szanto, M. Ristow, and A.C. Jozsi Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones J Clin Invest 112 2003 608 618
317. P. Ferre The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity Diabetes 53 Suppl. 1
318. N. Maeda, M. Takahashi, T. Funahashi, S. Kihara, H. Nishizawa, and K. Kishida PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein Diabetes 50 2001 2094 2099
319. M. Guerre-Millo, P. Gervois, E. Raspe, L. Madsen, P. Poulain, and B. Derudas Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity J Biol Chem 275 2000 16638 16642
320. T. Tanaka, J. Yamamoto, S. Iwasaki, H. Asaba, H. Hamura, and Y. Ikeda Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome Proc Natl Acad Sci USA 100 2003 15924 15929
321. K. Tordjman, C. Bernal-Mizrachi, L. Zemany, S. Weng, C. Feng, and F. Zhang PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null mice J Clin Invest 107 2001 1025 1034
322. M. Guerre-Millo, C. Rouault, P. Poulain, J. Andre, V. Poitout, and J.M. Peters PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance Diabetes 50 2001 2809 2814
323. S.Y. Park, Y.R. Cho, B.N. Finck, H.J. Kim, T. Higashimori, and E.G. Hong Cardiac-specific overexpression of peroxisome proliferator-activated receptor-{alpha} causes insulin resistance in heart and liver Diabetes 54 2005 2514 2524
324. S. Kersten, S. Mandard, N.S. Tan, P. Escher, D. Metzger, and P. Chambon Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene J Biol Chem 275 2000 28488 28493
325. J.C. Yoon, T.W. Chickering, E.D. Rosen, B. Dussault, Y. Qin, and A. Soukas Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation Mol Cell Biol 20 2000 5343 5349
326. X. Yu, S.C. Burgess, H. Ge, K.K. Wong, R.H. Nassem, and D.J. Garry Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart Proc Natl Acad Sci USA 102 2005 1767 1772
327. K. Yoshida, T. Shimizugawa, M. Ono, and H. Furukawa Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase J Lipid Res 43 2002 1770 1772
328. H. Ge, G. Yang, X. Yu, T. Pourbahrami, and C. Li Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4 J Lipid Res 45 2004 2071 2079
329. A. Koster, Y.B. Chao, M. Mosior, A. Ford, P.A. Gonzalez-Dewhitt, and J.E. Hale Transgenic Angptl4 overexpression and targeted disruption of Angptl4 and Angptl3: regulation of triglyceride metabolism Endocrinology 2005
330. S. Mandard, F. Zandbergen, E. van Straten, W. Wahli, F. Kuipers, and M. Müller The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity J Biol Chem 281 2006 934 944
331. A. Xu, M.C. Lam, K.W. Chan, Y. Wang, J. Zhang, and R.L. Hoo Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice Proc Natl Acad Sci USA 102 2005 6086 6091
332. T. Lemberger, B. Staels, R. Saladin, B. Desvergne, J. Auwerx, and W. Wahli Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids J Biol Chem 269 1994 24527 24530
333. T. Lemberger, R. Saladin, M. Vazquez, F. Assimacopoulos, B. Staels, and B. Desvergne Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm J Biol Chem 271 1996 1764 1769
334. C. Bernal-Mizrachi, S. Weng, C. Feng, B.N. Finck, R.H. Knutsen, and T.C. Leone Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice Nat Med 9 2003 1069 1075
335. J. Berger, M. Tanen, A. Elbrecht, A. Hermanowski-Vosatka, D.E. Moller, and S.D. Wright Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity J Biol Chem 276 2001 12629 12635
336. T.W. Dunlop, S. Vaisanen, C. Frank, F. Molnar, L. Sinkkonen, and C. Carlberg The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor J Mol Biol 349 2005 248 260
337. L. Michalik, J.N. Feige, L. Gelman, T. Pedrazzini, H. Keller, and B. Desvergne Selective expression of a dominant-negative form of peroxisome proliferator-activated receptor in keratinocytes leads to impaired epidermal healing Mol Endocrinol 19 2005 2335 2348
338. N. Di-Poi, B. Desvergne, L. Michalik, and W. Wahli Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins J Biol Chem 280 2005 38700 38710